As the Trump administration pushes for a COVID-19 vaccine to be distributed by November, a group of pharmaceutical companies banded together and signed a safety pledge to ensure they aren’t rushing this process.

The CEOs from Gaithersburg, Maryland-based Novavax; British companies AstraZeneca and GlaxoSmithKline; New Jersey-based Johnson & Johnson and Merck; Massachusetts-based Moderna Inc. and BioNTech; New York-based Pfizer; and Paris-based Sanofi signed a pledge to continue developing their coronavirus vaccines safely despite the pressure to speed up deployment.

The CEOs signed this pledge with patient safety in mind days after the Center for Disease Control and Prevention sent a letter to governors urging them to speed up the approval process for vaccine distribution centers for use by McKesson Corp. to Nov. 1 (coincidentally, two days before Election Day).

READ FULL ARTICLE HERE